---
title: "YIBAI PHARMACEUTICAL issues a profit warning, expecting a net loss of 285 million to 342 million yuan for the fiscal year 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225323256.md"
description: "YIBAI PHARMACEUTICAL expects a net loss of RMB 285 million to RMB 342 million for the fiscal year 2024, mainly due to the cessation of production and sales of Eddie injection, resulting in a decline in main business revenue of approximately RMB 480 million. In addition, the centralized procurement price reduction of injectable lobaplatin, ginkgo biloba injection, and compound cantharidin capsules has also led to a decrease in main business revenue of approximately RMB 190 million"
datetime: "2025-01-17T09:24:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225323256.md)
  - [en](https://longbridge.com/en/news/225323256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225323256.md)
---

# YIBAI PHARMACEUTICAL issues a profit warning, expecting a net loss of 285 million to 342 million yuan for the fiscal year 2024

According to the Zhitong Finance APP, YIBAI PHARMACEUTICAL (600594.SH) announced that the company expects to achieve a net loss attributable to the parent company's owners of between 285 million yuan and 342 million yuan for the fiscal year 2024, indicating a loss compared to the same period last year.

During the reporting period, the company's main product, Eddie injection, ceased production and sales, resulting in a significant decline in the company's main business revenue of approximately 480 million yuan and a substantial decrease in profit. Additionally, during the reporting period, the company's main business revenue decreased by approximately 190 million yuan and profit reduced due to the price drop from the centralized procurement of its products, including injection of lobaplatin, ginkgo biloba injection, and compound cantharidin capsules

### Related Stocks

- [600594.CN](https://longbridge.com/en/quote/600594.CN.md)
- [301517.CN](https://longbridge.com/en/quote/301517.CN.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Scott Jennings voices concern over Trump's $1.7B DOJ fund](https://longbridge.com/en/news/286922300.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [Tiger Group Sale Features Audiovisual Gear in Canada](https://longbridge.com/en/news/286775465.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)